These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 34717969)

  • 1. Downregulation of hsa-miR-203 in peripheral blood and wound margin tissue by negative pressure wound therapy contributes to wound healing of diabetic foot ulcers.
    Liu L; Chen R; Jia Z; Li X; Tang Y; Zhao X; Zhang S; Luo L; Fang Z; Zhang Y; Chen M
    Microvasc Res; 2022 Jan; 139():104275. PubMed ID: 34717969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative pressure wound therapy promotes wound healing of diabetic foot ulcers by up-regulating PRDX2 in wound margin tissue.
    Tang Y; Liu L; Jie R; Tang Y; Zhao X; Xu M; Chen M
    Sci Rep; 2023 Sep; 13(1):16192. PubMed ID: 37758743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA‑binding proteins through negative pressure wound therapy.
    Tang Y; Ji H; Yan Y; Hu D; Xu M; Xu M; Zhao X; Chen M
    Int J Mol Med; 2024 Nov; 54(5):. PubMed ID: 39301661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of miR-204-3p in peripheral blood and wound margin tissue associated with the onset and poor wound healing of diabetic foot ulcers.
    Zhao X; Xu M; Tang Y; Xie D; Deng L; Chen M; Wang Y
    Int Wound J; 2023 Feb; 20(2):413-429. PubMed ID: 35879811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in miroRNA-103 expression in wound margin tissue are related to wound healing of diabetes foot ulcers.
    Zhao X; Xu M; Tang Y; Xie D; Wang Y; Chen M
    Int Wound J; 2023 Feb; 20(2):467-483. PubMed ID: 35837786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-23c regulates wound healing by targeting stromal cell-derived factor-1α (SDF-1α/CXCL12) among patients with diabetic foot ulcer.
    Amin KN; Umapathy D; Anandharaj A; Ravichandran J; Sasikumar CS; Chandra SKR; Kesavan R; Kunka Mohanram R
    Microvasc Res; 2020 Jan; 127():103924. PubMed ID: 31520606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different treatment measures on the efficacy of diabetic foot ulcers: a network meta-analysis.
    OuYang H; Yang J; Wan H; Huang J; Yin Y
    Front Endocrinol (Lausanne); 2024; 15():1452192. PubMed ID: 39377075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative pressure wound therapy affects circulating plasma microRNAs in patients with diabetic foot ulceration.
    Kapusta P; Konieczny PS; Hohendorff J; Borys S; Totoń-Żurańska J; Kieć-Wilk BM; Wołkow PP; Malecki MT
    Diabetes Res Clin Pract; 2020 Jul; 165():108251. PubMed ID: 32531327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Negative Pressure Wound Therapy on Levels of Angiopoetin-2 and Other Selected Circulating Signaling Molecules in Patients with Diabetic Foot Ulcer.
    Hohendorff J; Drozdz A; Borys S; Ludwig-Slomczynska AH; Kiec-Wilk B; Stepien EL; Malecki MT
    J Diabetes Res; 2019; 2019():1756798. PubMed ID: 31781660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded negative pressure wound therapy in healing diabetic foot ulcers: a prospective randomised study.
    Campitiello F; Mancone M; Corte AD; Guerniero R; Canonico S
    J Wound Care; 2021 Feb; 30(2):121-129. PubMed ID: 33573486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics changes after negative pressure wound therapy in diabetic foot ulcers.
    Jia Z; Liu L; Zhang S; Zhao X; Luo L; Tang Y; Shen B; Chen M
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-203 Acts as an Inhibitor for Epithelial-Mesenchymal Transition Process in Diabetic Foot Ulcers via Targeting Interleukin-8.
    Yuan L; Sun Y; Xu M; Zeng F; Xiong X
    Neuroimmunomodulation; 2019; 26(5):239-249. PubMed ID: 31707396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0084443 Is Upregulated in Diabetic Foot Ulcer and Modulates Keratinocyte Migration and Proliferation.
    Wang A; Toma MA; Ma J; Li D; Vij M; Chu T; Wang J; Li X; Xu Landén N
    Adv Wound Care (New Rochelle); 2020 Apr; 9(4):145-160. PubMed ID: 32117579
    [No Abstract]   [Full Text] [Related]  

  • 14. Upregulation of circ_0080968 in diabetic foot ulcer inhibits wound healing via repressing the migration and promoting proliferation of keratinocytes.
    Fu Z; Jiang Z; Liao X; Liu M; Guo G; Wang X; Yang G; Zhou Z; Hu L; Xiong Z
    Gene; 2023 Oct; 883():147669. PubMed ID: 37500023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of miR-24 in peripheral plasma of type 2 diabetes mellitus patients associated with diabetic foot ulcer.
    Li X; Tang Y; Jia Z; Zhao X; Chen M
    Wound Repair Regen; 2020 Nov; 28(6):728-738. PubMed ID: 32710681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of negative pressure wound therapy on the outcome of diabetic foot ulcers: A meta-analysis.
    Zhang N; Liu Y; Yan W; Liu F
    Int Wound J; 2024 Apr; 21(4):e14886. PubMed ID: 38651532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Negative Pressure Wound Therapy (NPWT) on Healing of Diabetic Foot Ulcers: A Literature Review.
    Widigdo DAM; Sofro ZM; Pangastuti HS; Dachlan I
    Curr Diabetes Rev; 2024; 20(8):1-11. PubMed ID: 37921159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA miR-145-5p Inhibits Cutaneous Wound Healing by Targeting PDGFD in Diabetic Foot Ulcer.
    Wang C; Huang L; Li J; Liu D; Wu B
    Biochem Genet; 2024 Aug; 62(4):2437-2454. PubMed ID: 37950842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative pressure wound therapy use in diabetic foot syndrome-from mechanisms of action to clinical practice.
    Borys S; Hohendorff J; Frankfurter C; Kiec-Wilk B; Malecki MT
    Eur J Clin Invest; 2019 Apr; 49(4):e13067. PubMed ID: 30600541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations - short-term efficacy and long-term outcomes.
    Borys S; Hohendorff J; Koblik T; Witek P; Ludwig-Slomczynska AH; Frankfurter C; Kiec-Wilk B; Malecki MT
    Endocrine; 2018 Dec; 62(3):611-616. PubMed ID: 30099674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.